Alx Oncology Holdings Inc (ALXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Sales | 4,796 | 2,067 | 0 | 0 |
| Cost of Goods | 4,360 | 1,880 | N/A | N/A |
| Gross Profit | 436 | 187 | N/A | N/A |
| Operating Expenses | 19,979 | 14,751 | 0 | 0 |
| Operating Income | -19,183 | -13,684 | N/A | N/A |
| Interest Expense | 21 | 0 | 0 | 0 |
| Other Income | -5 | -2 | 0 | 0 |
| Pre-tax Income | -19,209 | -13,686 | 0 | 0 |
| Income Tax | 34 | 45 | N/A | N/A |
| Net Income Continuous | -19,243 | -13,731 | N/A | N/A |
| Net Income | $-19,243 | $-13,731 | $N/A | $N/A |
| EPS Basic Total Ops | -7.56 | -6.33 | N/A | N/A |
| EPS Basic Continuous Ops | -6.26 | -4.99 | N/A | N/A |
| EPS Diluted Total Ops | -7.56 | -6.33 | N/A | N/A |
| EPS Diluted Continuous Ops | -6.26 | -4.99 | N/A | N/A |
| EBITDA(a) | $-18,743 | $-13,253 | $N/A | $N/A |